Aimed Bio Valuation Multiples
Discover Aimed Bio's revenue and EBITDA valuation multiples and investment history.
Aimed Bio Overview
About Aimed Bio
Aimed Bio Inc is a preclinical-stage biotechnology company specializing in the development of antibody-based therapeutics, especially antibody-drug conjugates (ADC) and bispecific antibodies. It is a next-generation anticancer technology designed to maximize therapeutic efficacy and reduce side effects compared to existing chemotherapeutic agents by selectively delivering anticancer drugs to cancer cells via antibodies. Its product pipelines are AMB302, AMB303, AMB001, and Others.
Founded
2018
HQ
Employees
51
Website
Financials (FY)
EV
$1B
Valuation Multiples
Start free trial
Aimed Bio Stock Performance
Aimed Bio has current market cap of $1B, and enterprise value of $1B.
Aimed Bio's stock price is $15.99.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -5.6% | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAimed Bio Valuation Multiples
Aimed Bio Financial Valuation Multiples
As of July 9, 2026, Aimed Bio has market cap of $1B and EV of $1B.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Aimed Bio Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Aimed Bio Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Aimed Bio competitors and their valuation data. Start Free Trial | ||||||
Aimed Bio VC Funding History
Before going public, Aimed Bio raised $66M in total equity funding, across 2 rounds.
Aimed Bio Funding Rounds
Investments by Aimed Bio
Aimed Bio has invested in 1 company to date.
Latest investment by Aimed Bio was on June 30th 2026. Aimed Bio invested in Inocras in their Strategic investment round.
Latest Investments by Aimed Bio
| Description | Inocras is a San Francisco-headquartered genomics firm offering AI-analyzed whole genome sequencing. Its CAP/CLIA lab processes CancerVision for tumor profiling, RareVision for Mendelian disorders, and MRDVision for infectious agents. Inocras serves pharma partners like Genentech with proprietary pipelines on AWS, enabling clinical trials since 2021. |
| HQ Country |  |
| HQ City | San Diego, CA |
| Deal Date | 30 Jun 2026 |
| Round | Strategic investment |
| Raised | undisclosed |
| Investors | Aimed Bio |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Aimed Bio investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Aimed Bio
| When was Aimed Bio founded? | Aimed Bio was founded in 2018. |
| Where is Aimed Bio headquartered? | Aimed Bio is headquartered in South Korea. |
| How many employees does Aimed Bio have? | As of today, Aimed Bio has over 51 employees. |
| Is Aimed Bio publicly listed? | Yes, Aimed Bio is a public company listed on Korea Exchange. |
| What is the stock symbol of Aimed Bio? | Aimed Bio trades under 0009K0 ticker. |
| When did Aimed Bio go public? | Aimed Bio went public in 2025. |
| Who are competitors of Aimed Bio? | Aimed Bio main competitors include |
| What is the current market cap of Aimed Bio? | Aimed Bio's current market cap is $1B. |
| Is Aimed Bio profitable? | No, Aimed Bio is not profitable. |
| How many companies Aimed Bio has acquired to date? | Aimed Bio hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Aimed Bio has invested to date? | As of July 2026, Aimed Bio has invested in 1 company. |
| What was the last Aimed Bio investment? | On 30th June 2026 Aimed Bio invested in Inocras, participating in a Strategic investment round. |
| In what companies Aimed Bio invested in? | Aimed Bio invested in Inocras. |
Lists including Aimed Bio
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.